Biotech

Israeli biotech company Clearmind Medicine Inc CEO Dr. Adi Zuloff-Shani addresses letter to shareholders

Israeli biotech company Clearmind Medicine Inc CEO Dr. Adi Zuloff-Shani addresses letter to shareholders

Clearmind Medicine Inc. Tel Aviv, Israel / Vancouver, Canada, Dec. 15 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND) (FSE: CWY) (“Clearmind” or the “Company”)a biotechnology company developing therapies derived from psychedelics, has released the following letter to shareholders from its CEO, Dr. Adi Zuloff-Shani. Dear shareholders, Clearmind’s overriding mission since inception has …

Israeli biotech company Clearmind Medicine Inc CEO Dr. Adi Zuloff-Shani addresses letter to shareholders Read More »

3 biotech actions to reinvent mental health treatment

3 biotech actions to reinvent mental health treatment

Mental health issues are a growing concern in the United States. According to the National Institute of Mental Health (NIMH), almost 20% of adults, or 43 million people, suffer from some form of mental illness each year. Conditions can range from mild states like depression and anxiety to more serious conditions like dementia, bipolar disorder, …

3 biotech actions to reinvent mental health treatment Read More »

Intrinsic Medicine and Phoenix Biotech Acquisition Corp.  mutually agree to terminate the business combination agreement

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. mutually agree to terminate the business combination agreement

SEATTLE, 06 Dec. 12, 2022 (GLOBE NEWSWIRE) — Intrinsic Medicine, Inc. (Intrinsic), a therapeutic company leveraging breast milk biology to transform gut-brain axis (GBA) and inflammatory disorders, and Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (PBAX), a special purpose acquisition company sponsored by Phoenix Biotech Sponsor, LLC and formed for the purpose of acquiring or merging with …

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. mutually agree to terminate the business combination agreement Read More »